Evidence map›Paper›PMID 35948344›Full record

ArticleBMJ global health2022

Cost-effectiveness and sustainability of improved hospital oxygen systems in Nigeria.

Hamish R Graham, Ayobami A Bakare, Adejumoke Idowu Ayede, Joseph Eleyinmi, Oyaniyi Olatunde, Oluwabunmi R Bakare, Blessing Edunwale, Eleanor F G Neal, Shamim Qazi, Barbara McPake and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Hamish R GrahamCentre for International Child Health, University of Melbourne, MCRI, The Royal Children's Hospital, Parkville, Victoria, Australia hamish.graham@rch.org.au.ORCID 0000-0003-2461-0463
Ayobami A BakareDepartment of Community Medicine, University College Hospital Ibadan, Ibadan, Nigeria.ORCID 0000-0003-2456-7899
Adejumoke Idowu AyedeDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
Joseph EleyinmiDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
Oyaniyi OlatundeDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
Oluwabunmi R BakareDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
Blessing EdunwaleDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
Eleanor F G NealInfection and Immunity, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Shamim QaziIndependent Consultant Paediatrician, Geneva, Switzerland.
Barbara McPakeNossal Institute for Global Health, Melbourne, Victoria, Australia.
David PeelAshdown Consultants, Hartfield, UK.
Amy Z GrayCentre for International Child Health, University of Melbourne, MCRI, The Royal Children's Hospital, Parkville, Victoria, Australia.
Trevor DukeCentre for International Child Health, University of Melbourne, MCRI, The Royal Children's Hospital, Parkville, Victoria, Australia.
Adegoke G FaladeDepartment of Paediatrics, University College Hospital Ibadan, Ibadan, Nigeria.
University College Hospital, Ibadan · NGRoyal Children's Hospital · AUUniversity of Ibadan · NGMurdoch Children's Research Institute · AUThe George Institute for Global Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionImproving hospital oxygen systems can improve quality of care and reduce mortality for children, but we lack data on cost-effectiveness or sustainability. This study evaluated medium-term sustainability and cost-effectiveness of the Nigeria Oxygen Implementation programme.

methodsProspective follow-up of a stepped-wedge trial involving 12 secondary-level hospitals. Cross-sectional facility assessment, clinical audit (January-March 2021), summary admission data (January 2018-December 2020), programme cost data.

interventionpulse oximetry introduction followed by solar-powered oxygen system installation with clinical and technical training and support. PRIMARY OUTCOMES: (i) proportion of children screened with pulse oximetry; (ii) proportion of hypoxaemic (SpO

resultsPulse oximetry coverage for neonates and children remained high during follow-up (83% and 81%) compared with full oxygen system period (94% and 92%) and preintervention (3.9% and 2.9%). Oxygen coverage for hypoxaemic neonates/children was similarly high (94%/88%) compared with full oxygen system period (90%/82%). Functional oxygen sources were present in 11/12 (92%) paediatric areas and all (8/8) neonatal areas; three-quarters (15/20) of wards had a functional oximeter. Of 32 concentrators deployed, 23/32 (72%) passed technical testing and usage was high (median 10 797 hours). Estimated 5-year cost-effectiveness US$86 per patient treated, $2694-4382 per life saved and $82-125 per disability-adjusted life year-averted. We identified practical issues for hospitals and Ministries of Health wishing to adapt and scale up pulse oximetry and oxygen.

conclusionHospital-level improvements to oxygen and pulse oximetry systems in Nigerian hospitals have been sustained over the medium-term and are a highly cost-effective child pneumonia intervention.

Indexed as

HypoxiaOxygenPneumoniaChildClinical Trials as TopicCost-Benefit AnalysisCross-Sectional StudiesFollow-Up StudiesHospitalsHumansInfant, NewbornNigeriaProspective StudiesOxygenChild healthHealth economicsHealth services researchPaediatricsPneumonia

Identifiers

PMID35948344
PMCPMC9379491
OpenAlexW4291020642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.